CogState Ltd
ASX:CGS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/GP
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Valuation Scenarios
If EV/GP returns to its 3-Year Average (5.9), the stock would be worth AU$1.78 (29% downside from current price).
| Scenario | EV/GP Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 8.3 | AU$2.49 |
0%
|
| 3-Year Average | 5.9 | AU$1.78 |
-29%
|
| 5-Year Average | 7 | AU$2.09 |
-16%
|
| Industry Average | 3.1 | AU$0.92 |
-63%
|
| Country Average | 5.8 | AU$1.76 |
-29%
|
Forward EV/GP
Today’s price vs future gross profit
Peer Comparison
| Market Cap | EV/GP | P/E | ||||
|---|---|---|---|---|---|---|
| AU |
|
CogState Ltd
ASX:CGS
|
427.2m AUD | 8.3 | 27.4 | |
| JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
37.9T JPY | 13.6 | 227.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 6.7 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
25.9B USD | 8 | 28.5 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.1B AUD | 55.8 | 60 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 5.1 | 20.8 | |
| SE |
|
Sectra AB
STO:SECT B
|
49.7B SEK | 35.5 | 91.8 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.8B USD | 8.1 | 42.2 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 6.5 | 18.7 | |
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
261.1B INR | 8.8 | 40.3 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 17.3 | -328 |
Market Distribution
| Min | 0 |
| 30th Percentile | 3.4 |
| Median | 5.8 |
| 70th Percentile | 11.1 |
| Max | 27 768.2 |
Other Multiples
CogState Ltd
Glance View
Cogstate Ltd. is a global cognitive science company. The firm provides computerized cognitive tests across various domains and support electronic clinical outcome assessment (eCOA) solutions. The firm's segment includes Clinical trials, Healthcare and Research. In the Clinical trials segment, the Company's technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. Research segment offers various research studies and academic collaborations across various indication of diseases.
